GK470 is a Group IVA cytosolic phospholipase A2 (GIVA cPLA2) inhibitor with anti-inflammatory activity; it inhibits arachidonic acid release in SW982 fibroblast-like synoviocytes (IC50 = 0.6 μM); demonstrates anti-inflammatory efficacy comparable to methotrexate in a prophylactic collagen-induced arthritis model; and significantly reduces plasma PGE2 levels.